Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18036196rdf:typepubmed:Citationlld:pubmed
pubmed-article:18036196lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0380051lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C1367731lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0752046lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:18036196lifeskim:mentionsumls-concept:C1319635lld:lifeskim
pubmed-article:18036196pubmed:issue1lld:pubmed
pubmed-article:18036196pubmed:dateCreated2008-7-7lld:pubmed
pubmed-article:18036196pubmed:abstractTextThe c-Jun N-terminal kinase 1 (JNK1, mitogen-activated kinase 8; MAPK8) phosphorylates insulin receptor substrate-1 (IRS-1) at serine 307, which induces insulin resistance. MAPK8 activity is increased in obese insulin-resistant mice, whereas mapk8 (-/-) mice show decreased adiposity and improved insulin sensitivity. The aim of this study was to determine the relationship between single nucleotide polymorphisms (SNPs) of MAPK8 and type 2 diabetes (T2DM).lld:pubmed
pubmed-article:18036196pubmed:languageenglld:pubmed
pubmed-article:18036196pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036196pubmed:citationSubsetIMlld:pubmed
pubmed-article:18036196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036196pubmed:statusMEDLINElld:pubmed
pubmed-article:18036196pubmed:monthJullld:pubmed
pubmed-article:18036196pubmed:issn1365-2265lld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:NishidaWataru...lld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:YamadaKazuyaKlld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:OsawaHaruhiko...lld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:OnumaHiroshiHlld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:OchiMasaakiMlld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:ShimizuIkkiIlld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:FujiiYasuhisa...lld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:OhashiJunJlld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:MakinoHideich...lld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:TabaraYasuhar...lld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:MikiTetsuroTlld:pubmed
pubmed-article:18036196pubmed:authorpubmed-author:KawamotoRyuic...lld:pubmed
pubmed-article:18036196pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18036196pubmed:volume69lld:pubmed
pubmed-article:18036196pubmed:ownerNLMlld:pubmed
pubmed-article:18036196pubmed:authorsCompleteYlld:pubmed
pubmed-article:18036196pubmed:pagination36-44lld:pubmed
pubmed-article:18036196pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:meshHeadingpubmed-meshheading:18036196...lld:pubmed
pubmed-article:18036196pubmed:year2008lld:pubmed
pubmed-article:18036196pubmed:articleTitleThe G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.lld:pubmed
pubmed-article:18036196pubmed:affiliationDepartment of Molecular and Genetic Medicine, Ehime University Graduate School of Medicine, Ehime Japan. harosawa@m.ehime-u.ac.jplld:pubmed
pubmed-article:18036196pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18036196pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5599entrezgene:pubmedpubmed-article:18036196lld:entrezgene
entrez-gene:7020entrezgene:pubmedpubmed-article:18036196lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18036196lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18036196lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18036196lld:entrezgene